[Etiopathogenetic and therapeutic considerations on deafness of sudden onset].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003638:Deafness / Q000188:drug therapy* / Q000209:etiology; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007759:Labyrinth Diseases / Q000150:complications / Q000188:drug therapy*; D011343:Procaine / Q000627:therapeutic use; D014652:Vascular Diseases / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D014665:Vasodilator Agents; D011343:Procaine; D004877:Ergoloid Mesylates; D006854:Hydrocortisone
Consideraţii etiopatogenice şi terapeutice asupra surdităţii brusc instalate.